Results 161 to 170 of about 586,499 (386)
Abstract Acute severe ulcerative colitis increases the risk for cytomegalovirus (CMV) infection, particularly with the use of immunocompromising medications. We report a case of a 4‐year‐old with newly diagnosed very early onset inflammatory bowel disease presenting with acute severe colitis refractory to both corticosteroids and infliximab, whose ...
Alison Laxer +3 more
wiley +1 more source
Protection from herpes simplex virus type 1 lethal and latent infections by secreted recombinant glycoprotein B constitutively expressed in human cells with a BK virus episomal vector [PDF]
Roberto Manservigi +9 more
openalex +1 more source
The relationship between condom use and herpes simplex virus acquisition
Louise Melvin
semanticscholar +1 more source
Objectives Intra‐amniotic sludge is an independent risk factor for preterm birth. It consists of a biophysical sonographic finding in the amniotic fluid, formed by dense echogenic particles near the cervical internal orifice, due to sterile or infectious inflammatory processes.
Clarissa Chavez Ortiz Roberto +8 more
wiley +1 more source
Cold Sore, Cold Soul? An Examination of Orolabial Herpes in Film
The sociocultural phenomenon of herpes is attributed to two strains of the herpes simplex virus: herpes simplex virus type 1 (HSV-1) causes orolabial cold sores while herpes simplex virus type 2 (HSV-2) is typically identified in genital lesions, though ...
Alex C. HOLLIDAY +2 more
doaj
Cytokine levels in patients with multiple sclerosis and chronic neuroborreliosis
An imbalance in the production of proand anti-inflammatory cytokines plays an important role in the pathogenesis of multiple sclerosis (MS) and chronic neuroborreliosis (CNB).Objective: to perform a comparative analysis of cytokine production in patients
N. S. Baranova +7 more
doaj +1 more source
Efficacy of the Herpes Zoster Subunit Vaccine in Adults 70 Years of Age or Older.
Anthony L. Cunningham +30 more
semanticscholar +1 more source
ABSTRACT Background Baricitinib is a selective Janus kinase (JAK)1/JAK2 inhibitor approved in more than 70 countries for the treatment of moderate‐to‐severe atopic dermatitis (AD) in adults, and in over 30 countries for adolescents and children from age 2 years with moderate‐to‐severe AD, who are candidates for systemic therapy.
Antonio Costanzo +11 more
wiley +1 more source

